experimental infection
Showing 26 - 50 of >10,000
Gonococcal Infection Trial in Chapel Hill (Cefixime, Ceftriaxone, Ciprofloxacin)
Completed
- Gonococcal Infection
- Cefixime
- +4 more
-
Chapel Hill, North CarolinaUniversity of North Carolina Health Care - Infectious Diseases
Feb 26, 2021
COVID-19, Fatigue, Distress Respiratory Syndrome Trial in Ourense, Vigo (Experimental tests)
Not yet recruiting
- COVID-19
- +5 more
- Experimental tests
-
Ourense, Spain
- +6 more
Nov 28, 2022
COVID-19 Trial in Guadalajara (Ozone plasma)
Enrolling by invitation
- COVID-19
- Ozone plasma
-
Guadalajara, Jalisco, Mexico
- +1 more
Nov 9, 2021
Coronavirus, COVID-19 Respiratory Infection Trial in João Pessoa (Experimental group/ Active HD-tDCS, Control Group / Sham
Recruiting
- Coronavirus
- COVID-19 Respiratory Infection
- Experimental group/ Active HD-tDCS
- Control Group / Sham Group
-
João Pessoa, Paraiba, BrazilFederal University of Paraíba,Department of Psychology
Mar 18, 2022
Coronavirus COVID-19, Respiratory Infection Trial in João Pessoa, (Experimental group, Sham Control)
Recruiting
- Coronavirus COVID-19
- Respiratory Infection
- Experimental group
- Sham Control
-
João Pessoa,, Paraiba, BrazilFederal University of Paraíba,Department of Psychology
Mar 18, 2022
Anemia, Iron Deficiency, Vitamin A Deficiency, Cognitive Development Trial in Arba Minch (Intermittent iron supplement,
Completed
- Anemia, Iron Deficiency
- +3 more
- Intermittent placebo iron supplement
- +3 more
-
Arba Minch, EthiopiaArba Minch University
Dec 3, 2021
HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)
Active, not recruiting
- HIV-1-infection
- Vaccine
- Placebo
-
Kilifi, Kenya
- +3 more
Jun 21, 2022
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-493 coformulated with ABT-530
- (no location specified)
Jul 9, 2021
Influenza A H3N2 Trial in London (Lumee Oxygen Platform)
Completed
- Influenza A H3N2
- Lumee Oxygen Platform
-
London, United KingdomImperial Clinical Research Facility, Imperial College London
Jan 11, 2021
Prosthetic Joint Infection, Vancomycin, Joint Diseases Trial in Houston (Experimental Intraosseous vancomycin 500mg in 250 mL
Recruiting
- Prosthetic Joint Infection
- +2 more
- Experimental Intraosseous vancomycin 500mg in 250 mL NS
- Standard IV administration of vancomycin
-
Houston, TexasHouston Methodist Hospital
Aug 30, 2021
HIV Infection Trial in South Africa (ALVAC-HIV, Bivalent Subtype C gp120/MF59®, ALVAC-HIV (vCP2438) Placebo)
Completed
- HIV Infection
- ALVAC-HIV
- +3 more
-
Durban, KwaZulu-Natal, South Africa
- +4 more
Nov 3, 2021
Cesarean Wound Disruption, Cesarean Section; Infection Trial in Kolkata (Delayed primary closure of skin incision in Caesarean
Completed
- Cesarean Wound Disruption
- Cesarean Section; Infection
- Delayed primary closure of skin incision in Caesarean section in experimental group
- Primary closure of skin incision in Caesarean section in active comparator group
-
Kolkata, West Bengal, IndiaCalcutta National Medical College and Hospital
Sep 27, 2021
Abdominal Trauma, Abdominal Injury, Abdominal Infection Trial in Canada (Experimental: ABRO™ Binder Arm, Placebo Comparator:
Recruiting
- Abdominal Trauma
- +7 more
- Experimental: ABRO™ Binder Arm
- Placebo Comparator: Usual Care
-
New Westminster, British Columbia, Canada
- +3 more
Mar 8, 2022
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
Jul 8, 2021
Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)
Terminated
- Shigella
- CVD 1208S, a Shigella flexneri 2a live, oral vaccine
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore Center for Vaccine Development
Apr 27, 2021
Infection Control, Preventive Measures Trial in Madrid (Online training of a nursing technique)
Completed
- Infection Control
- Preventive Measures
- Online training of a nursing technique
-
Madrid, SpainHospital Universitario 12 de Octubre de Madrid
Mar 8, 2021
Intermittent Urethral Catheterization, Spinal Dysraphism, Urinary Tract Infections Trial in Trabzon (experimental group:
Active, not recruiting
- Intermittent Urethral Catheterization
- +2 more
- experimental group: Training of caregivers
- Control gruop
-
Trabzon, Health Faculty Of Health Sciences, Turkey
- +1 more
Feb 19, 2021
Multidisciplinary Mobile Unit for Preventing Hospitalization of
Terminated
- Frailty
- +5 more
- Multidisciplinary Mobile Unit (MMU)
-
Parma, Emilia-Romagna, ItalyUO Medicina Interna e Lungodegenza Critica, Azienda Ospedaliero-
Jan 12, 2021
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
SARS-CoV-2 Infection Trial in Spain (0.07% cetylpyridinium chloride (CPC) in mouthwash, Distilled water with the same colorant
Completed
- SARS-CoV-2 Infection
- 0.07% cetylpyridinium chloride (CPC) in mouthwash
- Distilled water with the same colorant as the experimental product
-
Badalona, Barcelona, Spain
- +18 more
Jul 13, 2021
Malaria Trial in Herston (OZ439, Primaquine)
Completed
- Malaria
-
Herston, Queensland, AustraliaQ-Pharm Clinics
May 7, 2020
COVID-19 Trial in Austria (Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care)
Unknown status
- COVID-19
- Chloroquine or Hydroxychloroquine
- +11 more
-
Innsbruck, Tirol, Austria
- +8 more
Feb 25, 2021
2019 Novel Coronavirus Infection Trial in Shiyan (recombinant human interferon Alpha-1b, thymosin alpha 1)
Unknown status
- 2019 Novel Coronavirus Infection
- recombinant human interferon Alpha-1b
- thymosin alpha 1
-
Shiyan, Hubei, ChinaTaihe Hospital
Mar 30, 2020